CBT
BIIB icon

Capital Bank & Trust’s Biogen BIIB Stock Holding History

Capital Bank & Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-115
Closed -$36K – 330
2020
Q1 		$36K Hold
115
– – ﹤0.01% 443
2019
Q4 		$34K Sell
115
-10
-8% -$2.77K ﹤0.01% 477
2019
Q3 		$29K Buy
125
+10
+9% +$2.33K ﹤0.01% 481
2019
Q2 		$27K Sell
115
-1
-0.9% -$231 ﹤0.01% 481
2019
Q1 		$27K Sell
116
-61
-34% -$19.2K ﹤0.01% 448
2018
Q4 		$53K Sell
177
-6
-3% -$1.92K ﹤0.01% 408
2018
Q3 		$65K Hold
183
– – ﹤0.01% 419
2018
Q2 		$53K Buy
183
+21
+13% +$5.9K ﹤0.01% 410
2018
Q1 		$44K Hold
162
– – ﹤0.01% 399
2017
Q4 		$52K Buy
162
+6
+4% +$1.93K ﹤0.01% 420
2017
Q3 		$49K Sell
156
-15
-9% -$4.44K ﹤0.01% 378
2017
Q2 		$46K Buy
+171
New +$45.2K ﹤0.01% 360

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital Bank & Trust's BIIB Position: Q2 2020 in Review

Capital Bank & Trust sold out of Biogen (BIIB) in Q2 2020, closing a stake of 115 shares — an estimated $36K sold.

Capital Bank & Trust first reported a position in BIIB in Q2 2017 and held it in 12 quarters. The position peaked at $65K in Q3 2018. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

  • Capital Bank & Trust reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
  • Capital Bank & Trust sold 115 Biogen shares in Q2 2020, an estimated $36K.
  • Capital Bank & Trust first reported a position in Biogen in Q2 2017 and held it in 12 quarters.
  • Capital Bank & Trust's Biogen position peaked at $65K in Q3 2018.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Capital Bank & Trust's 13F filing for Q2 2020, filed 14 Aug 2020.